PSC
STTK icon

Piper Sandler & Co’s Shattuck Labs STTK Stock Holding History

Piper Sandler & Co’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,467
Closed -$254K – 20
2026
Q1 		$254K Hold
39,467
– – 0.25% 16
2025
Q4 		$144K Hold
39,467
– – 0.1% 23
2025
Q3 		$94.3K Hold
39,467
– – 0.07% 21
2025
Q2 		$31.3K Hold
39,467
– – 0.02% 19
2025
Q1 		$37.5K Hold
39,467
– – 0.03% 25
2024
Q4 		$47.8K Hold
39,467
– – 0.04% 26
2024
Q3 		$138K Hold
39,467
– – 0.09% 31
2024
Q2 		$152K Hold
39,467
– – 0.12% 13
2024
Q1 		$353K Hold
39,467
– – 0.24% 14
2023
Q4 		$281K Hold
39,467
– – 0.21% 15
2023
Q3 		$60K Hold
39,467
– – 0.06% 9
2023
Q2 		$123K Hold
39,467
– – 0.13% 15
2023
Q1 		$116K Hold
39,467
– – 0.08% 24
2022
Q4 		$90.8K Hold
39,467
– – 0.09% 28
2022
Q3 		$107K Hold
39,467
– – 0.09% 31
2022
Q2 		$160K Hold
39,467
– – 0.15% 32
2022
Q1 		$168K Sell
39,467
-69,468
-64% -$394K 0.13% 23
2021
Q4 		$5.71M Buy
108,935
+30,000
+38% +$413K 4.11% 7
2021
Q3 		$1.61M Hold
78,935
– – 2.19% 7
2021
Q2 		$2.29M Sell
78,935
-30,000
-28% -$877K 2.13% 8
2021
Q1 		$3.19M Hold
108,935
– – 2.64% 11
2020
Q4 		$5.71M Buy
+108,935
New +$3.5M 4.11% 7

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Piper Sandler & Co's STTK Position: Q2 2026 in Review

Piper Sandler & Co sold out of Shattuck Labs (STTK) in Q2 2026, closing a stake of 39,467 shares — an estimated $254K sold.

Piper Sandler & Co first reported a position in STTK in Q4 2020 and held it in 22 quarters. The position peaked at $5.71M in Q4 2021. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Piper Sandler & Co reported no remaining Shattuck Labs position as of Q2 2026 after selling out during the quarter.
  • Piper Sandler & Co sold 39,467 Shattuck Labs shares in Q2 2026, an estimated $254K.
  • Piper Sandler & Co first reported a position in Shattuck Labs in Q4 2020 and held it in 22 quarters.
  • Piper Sandler & Co's Shattuck Labs position peaked at $5.71M in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Piper Sandler & Co's 13F filing for Q2 2026, filed 28 Jul 2026.